Intrapulmonary Percussive Ventilator (IPV) — NCD 229 | CMS Coverage Update

CMS confirmed that intrapulmonary percussive ventilation is not covered under Medicare for home use, effective March 7, 2026. Here's what billing teams need to do.

The Centers for Medicare & Medicaid Services modified NCD 229 — the National Coverage Determination governing Medicare coverage of intrapulmonary percussive ventilators (IPV) for home use — with an effective date of March 7, 2026. The policy's position is unambiguous: IPV in the home setting is not covered. The policy does not list specific CPT or HCPCS codes, which creates its own set of billing headaches you need to plan for now.

Quick-Reference Table

CMS Intrapulmonary Percussive Ventilator Coverage Criteria and Medical Necessity Requirements 2026

Here's the short version: there are no coverage criteria, because CMS covers nothing.

NCD 229 under the NCD 229 Medicare system is a flat denial for IPV in the home setting. The policy states that studies do not show any advantage of IPV over standard pulmonary care in the hospital environment. Crucially, CMS notes there are no studies at all conducted in the home setting. Without that evidence base, the agency won't support reimbursement.

The real issue here is that "no data" is doing a lot of work in this coverage policy. CMS isn't saying IPV is harmful. It's saying IPV hasn't been proven effective in the home environment, which is the only environment this NCD governs. That's a meaningful distinction if you're advising a physician who uses IPV in an inpatient or outpatient hospital setting — those settings are not blocked by this NCD.

Medical necessity doesn't enter the conversation for home-use IPV under Medicare. It doesn't matter how severe the patient's COPD is, how thick their secretions are, or how many other therapies they've failed. The coverage policy blocks this service categorically. No amount of clinical documentation establishes medical necessity that overrides a national non-coverage determination.

Prior authorization is also irrelevant here. Prior auth is a gate you go through when coverage is possible but requires approval. NCD 229 doesn't gate — it bars. There's no prior authorization pathway that unlocks home IPV coverage under Medicare.

If you're billing for IPV in any setting, you need to know exactly where your claims sit. Inpatient and outpatient hospital claims are outside the scope of this NCD. DME suppliers and home health agencies billing for IPV devices and services delivered at home are directly in the crosshairs of this policy.

CMS Intrapulmonary Percussive Ventilator Exclusions and Non-Covered Indications

This entire NCD is an exclusion. But it's worth being precise about what it covers and what it doesn't — because the scope of the exclusion matters for your billing team.

NCD 229 excludes IPV specifically in the home setting. The policy describes IPV as a mechanized form of chest physical therapy. It delivers more than 200 mini-bursts of respiratory gases per minute via mouthpiece. The intended purpose is to mobilize endobronchial secretions and diffuse patchy atelectasis — the same goals as manual chest physiotherapy. The patient controls inspiratory time, peak pressure, and delivery rates.

CMS isn't disputing what IPV does mechanically. The agency is disputing whether it works better than the alternative — standard pulmonary care — in a home environment. The absence of home-setting studies is fatal to coverage under this policy.

The clinical framing here matters if you're handling appeals or writing denial responses. The policy doesn't call IPV experimental or investigational in a general sense. It calls IPV unproven specifically for home use. That's a narrower claim. Don't conflate the two when communicating with patients or writing ABN language.

Coverage Indications at a Glance

CMS Intrapulmonary Percussive Ventilator Billing Guidelines and Action Items 2026

If you're managing a large pulmonology or home health book of business, talk to your compliance officer before the effective date. The interaction between this NCD, your ABN processes, and any active DME rental agreements is complex enough to warrant a formal compliance review.

CPT, HCPCS, and ICD-10 Codes for Intrapulmonary Percussive Ventilation Under NCD 229

No Codes Listed in NCD 229

NCD 229 does not list specific CPT codes, HCPCS codes, or ICD-10-CM diagnosis codes. This is a real problem for IPV billing, and your team needs to understand why.

When a CMS coverage policy lists no codes, the billing implication is that the non-coverage determination applies to any claim — regardless of what code is used — for the described service in the described setting. You can't work around a code-free NCD by selecting a different HCPCS code for the IPV device. The service itself is what's excluded.

For IPV devices billed as durable medical equipment, your DME billing team should know that any applicable HCPCS code used to bill an IPV device for home use falls under this NCD's non-coverage scope. The absence of a code table in the policy doesn't create a billing loophole — it closes one.

If you're unsure which HCPCS codes your DME supplier or billing system currently maps to IPV devices, pull that list now and confirm how those claims are categorized. Then run them against this NCD. If you need guidance on specific code applicability, contact your Medicare Administrative Contractor directly. MACs can provide clarification on how NCD 229 applies to specific codes you're using.

What to Do Without a Code List

Work with your MAC and coding team to identify the specific HCPCS E-codes your organization has been using for IPV equipment. Document that mapping. Then apply NCD 229's non-coverage determination to any home-setting claims using those codes. This is basic but critical — don't assume the absence of codes in the NCD protects you from denials.